Difference between revisions of "FGF14-AS2"
(→Expression) |
|||
| Line 9: | Line 9: | ||
NR_036487 | NR_036487 | ||
===Expression=== | ===Expression=== | ||
| − | [[File:FGF14-AS2 expression in breast cancer in validated cohort | + | [[File:FGF14-AS2 expression in breast cancer in validated cohort.jpg|right|thumb|400px|'''FGF14-AS2 expression in breast cancer in validated cohort.'''<ref name="ref1" />]] |
| − | |||
<ref name="ref1" />. | <ref name="ref1" />. | ||
| Line 24: | Line 23: | ||
|} | |} | ||
Compared with adjacent non-cancerous breast tissues, FGF14-AS2 is down-regulated in breast cancer.<ref name="ref1" /> | Compared with adjacent non-cancerous breast tissues, FGF14-AS2 is down-regulated in breast cancer.<ref name="ref1" /> | ||
| + | |||
===pubmed IDs=== | ===pubmed IDs=== | ||
26820525 | 26820525 | ||
Revision as of 06:44, 15 October 2017
Contents
Annotated Information
Approved Symbol
FGF14-AS2 (FGF14 antisense RNA 2)
Chromosome
13q33.1
RefSeq ID
NR_036487
RefSeq(supplied by NCBI)
NR_036487
Expression
FGF14-AS2 expression in breast cancer in validated cohort.[1]
[1].
| Experiment | Forward primer | Reverse primer |
|---|---|---|
| qRT-PCR | 5'-AGTTCCAGTTACCATCTTCA- 3' | 5'-AGGTTCATAGTTGCCAGAC- 3'[1] |
Compared with adjacent non-cancerous breast tissues, FGF14-AS2 is down-regulated in breast cancer.[1]
pubmed IDs
26820525
Disease
breast cancer
Labs working on this lncRNA
- Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
